Serkan ENÖN, Hakan KUTLAY, Elif DUMAN, Murat ŞAHİN, Murat AKAL, Cabir YÜKSEL, Gökhan KOCAMAN, Mehmet Ali SAKALLI, Murat ÖZKAN, Mustafa Bülent YENİGÜN, Ayten KAYI CANGIR

Erken evre küçük hücreli dışı akciğer kanserinde sublobar rezeksiyonlar

Amaç: Bu çalışmada erken evre küçük hücreli dışı akciğer kanserli hastalarda sublobar rezeksiyonların sonuçları değerlendirildi ve sağkalımı etkileyen faktörler araştırıldı. Çalışma planı: Ocak 2011 - Ağustos 2013 tarihleri arasında şüpheli veya bilinen erken evre küçük hücreli dışı akciğer kanseri nedeniyle sublobar rezeksiyon yapılan toplam 63 hastanın (52 erkek, 11 kadın; ort. yaş 64 yıl; dağılım 39-81 yıl) tıbbi dosyası retrospektif olarak değerlendirildi. Hastaların demografik özellikleri, eşlik eden hastalıklar, sigara içiciliği, cerrahi sınır, viseral plevra invazyonu, tümörün cerrahi sınıra uzaklığı, tümör boyutu, patolojik N durumu, hücre tipi, tümör yerleşim yeri ve nüksler kaydedildi. Bulgular: Sağkalım, cerrahi sınırı tümör için negatif olan (R0) hastalarda, pozitif olan (R1) hastalara kıyasla, anlamlı olarak daha uzun (32.2 aya kıyasla 74.1 ay, p

Sublobar resections in early-stage non-small cell lung cancer

Background: This study aims to evaluate the outcomes ofsublobar resections in patients with early-stage non-small celllung cancer and to investigate the factors affecting survival.Methods: Medical files of a total of 63 patients (52 males,11 females; mean age 64 years; range, 39 to 81 years) whounderwent sublobar resection for suspected or known early-stagenon-small cell lung cancer between January 2001 and August2013 were retrospectively reviewed. Data including demographiccharacteristics of the patients, comorbid conditions, smokingstatus, surgical margin, visceral pleura invasion, distance fromsurgical margin to tumor, tumor size, pathological N status, celltype, tumor localization, and recurrences were recorded.Results: Survival was significantly longer in the patients withnegative surgical margin for tumor (R0) than in those withpositive margin (R1) (94.1 months vs. 32.2 months, p

PDF

___

1. Fell SC, Kirby TJ. Segmenter resection. In: Pearson FG, Cooper JD, Deslauriers J, Ginsberg RJ, Hiebert C, Patterson GA, et al, editors. Thoracic Surgery. 2nd ed. New York: Churchill Livingstone; 2002. p. 991-1001.
2. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-22.
3. National Comprehensive Cancer Network. Non-Small Cell Lung Cancer (Version 5.2019_June 7, 2019). Available on: https://www.nccn.org/professionals/physician_gls/pdf/nscl. pdf. [Accessed: June 29, 2019].
4. Liu T, Liu H, Li Y. Early lung cancer in the elderly: sublobar resection provides equivalent long-term survival in comparison with lobectomy. Contemp Oncol (Pozn) 2014;18:111-5.
5. Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJ, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005;128:237-45.
6. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, et al. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy. Chest 2014;145:66-71.
7. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg 2005;129:87-93.
8. Fan J, Wang L, Jiang GN, Gao W. Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a metaanalysis of published studies. Ann Surg Oncol 2012;19:661-8.
9. Ketchedjian A, Daly B, Landreneau R, Fernando H. Sublobar resection for the subcentimeter pulmonary nodule. Semin Thorac Cardiovasc Surg 2005;17:128-33.
10. Fernando HC, Santos RS, Benfield JR, Grannis FW, Keenan RJ, Luketich JD, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;129:261-7.
11. Higashiyama M, Kodama K, Takami K, Higaki N, Nakayama T, Yokouchi H. Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer. J Thorac Cardiovasc Surg 2003;125:101-7.
12. Sawabata N, Ohta M, Matsumura A, Nakagawa K, Hirano H, Maeda H, et al. Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study. Ann Thorac Surg 2004;77:415-20.
13. Schuchert MJ, Pettiford BL, Keeley S, D’Amato TA, Kilic A, Close J, et al. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg 2007;84:926-32.
14. El-Sherif A, Fernando HC, Santos R, Pettiford B, Luketich JD, Close JM, et al. Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol 2007;14:2400-5.
15. Koike T, Koike T, Yoshiya K, Tsuchida M, Toyabe S. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2013;146:372-8.
16. Higgins KA, Chino JP, Ready N, D’Amico TA, Berry MF, Sporn T, et al. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy. J Thorac Oncol 2012;7:1141-7.
17. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, et al. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study. J Thorac Cardiovasc Surg 2013;146:358-64.
18. De Zoysa MK, Hamed D, Routledge T, Scarci M. Is limited pulmonary resection equivalent to lobectomy for surgical management of stage I non-small-cell lung cancer? Interact Cardiovasc Thorac Surg 2012;14:816-20.